Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine]

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1984-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00504994PMID 6493353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of ischemic stress during repeated coronary artery occlusion in the dog a method for validation of therapeutic effects

  2005cited by this paper
• Quantification of ischemic stress during repeated coronary artery occlusion in the dog A method for validation of therapeutic effects

  2005cited by this paper
• Influence of Myocardial Substrate Utilization on the Oxygen Consumption of the Heart

  1982cited by this paper
• The influence of myocardial edema formation on the energy consumption of the heart during aerobiosis and hypoxia

  1982cited by this paper
• Dependency of location of salvageable myocardium on type of intervention.

  1981cited by this paper
• Mechanism of action of oxfenicine on muscle metabolism.

  1981cited by this paper
• Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.

  1981cited by this paper
• Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart.

  1980cited by this paper
• Potential protective value of enhanced myocardial carbohydrate utilisation with reduced free fatty acid uptake after UK 25842 in patients with coronary artery disease [proceedings].

  1979cited by this paper
• Validity of myocardial oxygen consumption parameters

  1979cited by this paper
• Experimental validation of methods for the measurement of coronary sinus blood flow in man

  1979cited by this paper
• Protection against experimental myocardial ischaemia by L-4-hydroxy-phenylglycine, a new agent which alters myocardial metabolic balance in favour of carbohydrate utilisation [proceedings].

  1979cited by this paper
• Methodon der enzymatischen Analyse, Hans Ulrich Bergmeyer (Ed.). Verl. Chemie, Weinheim (1974)

  1975cited by this paper
• Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction

  1975cited by this paper
• Effect of Coronary Blood Flow on Glycolytic Flux and Intracellular pH in Isolated Rat Hearts

  1975cited by this paper
• Methoden der enzymatischen Analyse. Herausgeg. von H. U. Bergmeyer. Verlag Chemie GmbH, Weinheim/Bergstr. 1970. 2. Aufl., LXIX, 2220 S., zahlr. Abb., geb. DM 285.—

  1971cited by this paper
• Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.

  1971cited by this paper
• Effect of Fatty Acids on Contractility and Rhythm of the Heart

  1970cited by this paper
• Depression of Myocardial Contractility in Rats by Free Fatty Acids during Hypoxia

  1970cited by this paper
• The glucose hypothesis: Relation to acute myocardial ischaemia

  1970cited by this paper
• The Depressant Effect of Fatty Acids on the Isolated Rabbit Heart∗

  1969cited by this paper
• Potassium, glucose, and insulin treatment for acute myocardial infarction.

  1969cited by this paper
• Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction.

  1969cited by this paper
• Effect of free fatty acid on the oxygen consumption of perfused rat heart.

  1966cited by this paper
• Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report.

  1962cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective.

  2017cites this paper
• solutionto the cardioprotective effect of GIK An increase in the redox state during reperfusion

  2015cites this paper
• An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution.

  2012cites this paper
• The effect of CPT-1 inhibition on myocardial function and resistance to ischemia/reperfusion injury in a rodent model of the metabolic syndrome

  2010cites this paper
• Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators.

  2008cites this paper
• Untersuchungen zur Regulation des Glucosetransportes durch cGMP in isolierten Herzmuskelzellen adulter Ratten

  2003cites this paper
• Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin.

  2002cites this paper
• The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

  2002cites this paper
• Impact of cellular pathways of fatty acid metabolism and cholesterol synthesis on cardiomyocyte cell death

  2002cites this paper
• Myocardial metabolism during graded intraportal verapamil infusion in awake dogs.

  1996cites this paper
• Mildronate: Mechanisms of action and prospects for correction of pathologic states

  1995cites this paper
• Inhibition of Long‐Chain Acylcarnitine Accumulation During Coronary Artery Occlusion Does Not Alter Infarct Size in Dogs

  1994cites this paper
• Role of fatty acid metabolites in the development of myocardial ischemic damage.

  1992cites this paper
• [Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate].

  1991cites this paper
• [The energetics and economics of the cardiac pump function].

  1991cites this paper
• Search for antidiabetic and cardioprotective drugs among inhibitors of β-oxidation (a review of the literature)

  1991cites this paper
• Heterogeneity of myocardial blood flow under normal conditions and its dependence on arterial PO2.

  1990cites this paper
• [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].

  1990cites this paper
• Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.

  1990cites this paper
• [Regulation of carnitine-dependent metabolism of fatty acids in the rat myocardium using 3-(2,2,2-trimethylhydrazinium) propionate].

  1989cites this paper
• Oxfenicine-induced accumulation of lipid in the rat myocardium.

  1988cites this paper
• Anaesthesia and ischaemic heart disease: laboratory results.

  1988cites this paper
• Are isolated cardiomyocytes a suitable experimental model in all lines of investigation in basic cardiology?

  1988cites this paper
• [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].

  1988cites this paper
• [Biochemical characteristics of the anti-ischemic action of the new structural analog of gamma-butyrobetaine 3-(2,2,2,-trimethylhydrazine)propionate].

  1987cites this paper
• [Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level].

  1987cites this paper
• Effectiveness of nicorandil in the preservation of myocardium stressed by transient ischemia and its influence on cardiac metabolism during coronary artery occlusion with subsequent reperfusion: a comparison with isosorbide dinitrate

  1985cites this paper